Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

ProQR hosts second R&D Day
September 2017
SHARING OPTIONS:

LEIDEN, The Netherlands—ProQR Therapeutics N.V. hosted its R&D Day this past quarter, an event that highlighted its product candidates and pipeline progress and featured talks by key opinion leaders. The company has two clinical programs and one preclinical program in its pipeline, with two programs about to enter development. ProQR also introduced Axiomer, its new RNA platform technology.
 
“While our focus and priority is on clinical development of our most advanced RNA-based therapeutics to help patients with CF, LCA 10 and DEB, we continue to innovate in RNA science. This innovation effort has led to the discovery of a novel RNA editing technology that we believe can address the underlying cause of a broad range of genetic defects at the RNA level,” said CEO Daniel de Boer. “The invention and patenting of Axiomer can drive drug discovery and development of a new class of therapeutics, independently and through partnerships.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.